elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q35050195-839BDE51-AEAC-4B47-81AB-D05FF96C4D90
Q35050195-839BDE51-AEAC-4B47-81AB-D05FF96C4D90
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35050195-839BDE51-AEAC-4B47-81AB-D05FF96C4D90
Anticancer activity of the type I insulin-like growth factor receptor antagonist, ganitumab, in combination with the death receptor 5 agonist, conatumumab.
P304
Q35050195-839BDE51-AEAC-4B47-81AB-D05FF96C4D90
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35050195-839BDE51-AEAC-4B47-81AB-D05FF96C4D90
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
baa26220c56b381126130f6ee4f22153d9b0fd2b
P304
65-76
http://www.w3.org/2001/XMLSchema#string